The Top Line

June 17, 2022


Listen Later

While revenue reflects how well a company’s products are selling, profit is the financial metric that really matters. It tells investors how efficiently a company is managed and how healthy the business is overall. We’ve taken a look at these bottom line figures and compiled a list of the top 10 most profitable pharma companies. But that's not all. The FDA advisory committee meeting met last Thursday and Friday, and the stakes were high. Bluebird bio came away on top. The committee endorsed two of its gene therapy candidates. Lastly, we’re all celebrating here at Fierce because our team’s faces are plastered on billboards at BIO International Convention. And we sent one shoe-leather reporter on a wild goose chase to find them. 

To learn more about the topics in this episode: 

  • The top 10 most profitable pharma companies in 2021
  • Pfizer already agreed to delay supply of COVID-19 shots to EU, now the bloc wants more
  • GSK hails phase 3 win for RSV vaccine in older adults, sparking race to regulators
  • Rune Labs translates Apple Watch data into Parkinson's insights with FDA nod
  • Bluebird gene therapy overcomes safety worries to snag a win at FDA advisory panel
  • Bluebird scores 2nd straight win at high-stakes FDA gene therapy meeting
  • Amid FDA delay, Amylyx scores conditional ALS drug nod in Canada
  • Eli Lilly's Olumiant snags biopharma's first FDA green light for alopecia areata
  • Alnylam's next-gen RNA drug Amvuttra wins FDA approval—and a Pfizer showdown may await
  • Ekso Bionics nabs FDA exoskeleton clearance for multiple sclerosis rehabilitation
  • Pfizer gives up on Paxlovid in less vulnerable COVID patients after data fail to impress
  • The Top Line is produced by senior multimedia producer Teresa Carey with editor-in-chief Tracy Staton, managing editor Querida Anderson and senior editors Annalee Armstrong, Ben Adams, Conor Hale and Eric Sagonowsky. The sound engineer is Caleb Hodgson. The stories are by all our “Fierce” journalists. 

    See omnystudio.com/listener for privacy information.

    ...more
    View all episodesView all episodes
    Download on the App Store

    The Top LineBy Fierce Life Sciences

    • 4.1
    • 4.1
    • 4.1
    • 4.1
    • 4.1

    4.1

    12 ratings


    More shows like The Top Line

    View all
    Motley Fool Hidden Gems Investing by The Motley Fool

    Motley Fool Hidden Gems Investing

    3,228 Listeners

    WSJ Your Money Briefing by The Wall Street Journal

    WSJ Your Money Briefing

    1,713 Listeners

    WSJ What’s News by The Wall Street Journal

    WSJ What’s News

    4,420 Listeners

    Masters in Business by Bloomberg

    Masters in Business

    2,175 Listeners

    The McKinsey Podcast by McKinsey & Company

    The McKinsey Podcast

    386 Listeners

    Odd Lots by Bloomberg

    Odd Lots

    1,993 Listeners

    Trumponomics by Bloomberg

    Trumponomics

    355 Listeners

    WSJ Tech News Briefing by The Wall Street Journal

    WSJ Tech News Briefing

    1,649 Listeners

    HBR IdeaCast by Harvard Business Review

    HBR IdeaCast

    154 Listeners

    FT Tech Tonic by Financial Times

    FT Tech Tonic

    96 Listeners

    Masters of Scale by WaitWhat

    Masters of Scale

    3,992 Listeners

    Bold Names by The Wall Street Journal

    Bold Names

    1,448 Listeners

    The Readout Loud by STAT

    The Readout Loud

    337 Listeners

    BioCentury This Week by BioCentury

    BioCentury This Week

    34 Listeners

    HBR On Leadership by Harvard Business Review

    HBR On Leadership

    170 Listeners